Tag

Advertisement

AstraZeneca

Dave Fredrickson

AstraZeneca’s Enhertu approved in the US

May 11, 2022

AstraZeneca and Daiichi Sankyo’s Enhertu …

Susan Galbraith

AstraZeneca’s Imfinzi plus chemotherapy granted Priority Review

May 6, 2022

AstraZeneca’s supplemental Biologics License Application …

Marc Dunoyer

AstraZeneca’s Ultomiris approved in the US

May 4, 2022

Ultomiris has been approved for …

AstraZeneca Boston

AstraZeneca announces plans for new strategic R&D centre

May 2, 2022

AstraZeneca has announced plans to …

Susan Galbraith

AstraZeneca’s tremelimumab accepted under Priority Review in the US

April 27, 2022

AstraZeneca’s Biologics License Application (BLA) …

Maihara Factory Japan

AstraZeneca’s Ondexxya approved in Japan

March 29, 2022

Ondexxya has been approved in …

AstraZeneca scientist

AstraZeneca’s Evusheld approved in the EU

March 28, 2022

AstraZeneca’s Evusheld, a long-acting antibody …

Susan Galbraith

AstraZeneca’s CALLA trial did not achieve statistical significance for the primary endpoint

March 28, 2022

The CALLA Phase III trial …

AstraZeneca’s Evusheld recommended for approval in the EU

March 25, 2022

AstraZeneca’s Evusheld, a long-acting antibody …

Marc Dunoyer

AstraZeneca reaches settlement agreement

March 17, 2022

Alexion, AstraZeneca’s Rare Disease group, …

AstraZeneca and Business Tampere offer a mentoring program

March 16, 2022

AstraZeneca offers ”one-off” business mentoring …

Dave Fredrickson

AstraZeneca’s Lynparza approved in the US

March 15, 2022

AstraZeneca and MSD’s Lynparza has …

New results from AstraZeneca’s MELODY trial

March 7, 2022

Detailed results from the MELODY …

AstraZeneca and Neurimmune close collaboration and licence agreement

March 1, 2022

Alexion, AstraZeneca’s Rare Disease group, …

Pascal Soriot

AstraZeneca enters partnership with Honeywell

February 23, 2022

The two companies will partner …

AstraZeneca Research and Development

Updated results from AstraZeneca’s ASCEND trial

January 20, 2022

Updated results from the ASCEND …

1
2
3
···
24